Spark Plug Pipe

CORAL GABLES, FL / ACCESSWIRE / January 23, 2019 / The marijuana stock market has remained incredibly interesting and full of life for the better part of two years at this point. With countless new innovations and updates to everything from cannabis legislation to nuanced applications of products in treatment and healthcare, it seems as though we are entering a new phase of cannabis throughout the whole market. As the market continues to garner favorable opinion, investor interest is following suit, resulting in companies actively seeking new applications for cannabis across a myriad of sectors and industries. The overwhelming majority of the population has expressed their support in terms of legalizing marijuana, resulting in the cannabis sector showing exciting promise for investors. As we enter the closing weeks of January, Premier Health Group (OTC:PHGRF) (CNSX:PHGI.CN) , Canopy Growth Corp. (TSX:CGC.TO) (TSX:WEED.TO), GW Pharmaceuticals plc (NASDAQ:GWPH), and Cronos Group Inc. (NASDAQ:CRON) are four pot stocks representing companies looking to push the limits of their sector.

Premier Health Group (OTC:PHGRF) (CNSX:PHGI.CN) is a company focused on investing in opportunities and products to foster the growing relationship between the cannabis and healthcare sectors. Following significant legislation passed over the last few months, the Company has seen impressive growth while simultaneously impressing investors with exciting announcements demonstrating their commitment to innovation.

Towards the end of last week, Premier Health Group (OTC:PHGRF) (CNSX:PHGI.CN) announced that as part of its international expansion strategy, it has entered into a strategic partnership with China’a 360 Health, a healthcare subsidiary of 360 Security Technology. The parent company, 360 Security Technology, is a leading online service company in China with a market capitalization of over $20 billion USD as of January 16, 2019. As part of the collaboration, Premier and 360 Health will implement an infrastructure whereby Premier will be providing second opinion services by connecting 360 Health’s patients in China with doctors in Canada both remotely and in person. Premier will also assist with General Practitioner training virtually and onsite through medical seminars.

In response to this announcement , Dr. Essam Hamza, CEO of Premier, said, ”We are very excited to be working with 360 Health as China continues to adopt a Family Practice primary care model and look forward to helping them establish themselves as a leader in primary care. This partnership represents an excellent opportunity for Premier to tap into the fastest growing telemedicine market globally.”

For More Information On Premier Health Group, Click Here

Canopy Growth Corp (CGC) (WEED) made several announcements on Tuesday regarding key milestones for progress in the European cannabis market, specifically in the UK and Poland where its medically-focused business Spectrum Cannabis continues to build a sophisticated, pan-European cannabis production and distribution network.

Dr. Mark Ware, Chief Medical Officer, Canopy Growth, commented on the announcement, and said, ”There is significant real-world and clinical evidence supporting the safety and effectiveness of cannabis-based medicinal products. However, due to the current regulations and lack of education about medicinal cannabis among clinicians in the UK, there remain considerable obstacles to patient access. Spectrum UK has the expertise and ambition to simplify the UK medicinal cannabis landscape and ensure access to cannabis-based medicinal products for patients with great clinical unmet need.”

For More Information On Canopy Growth Corp., Click Here

GW Pharmaceuticals plc (GWPH), a biopharmaceutical company focused on discovering, developing and commercializing treatment options from its proprietary cannabinoid platform, announced towards the end of December 2018, that Justin Gover, Chief Executive Officer of GW, would present a company update at the J.P Morgan 2019 Healthcare Conference in San Francisco, CA on Tuesday, January 8, 2019. Though no formal announcements have been made regarding the result of the Company’s presentation, shares of GW have increased by 21.45% since the day of the presentation.

For More Information on GW Pharmaceuticals plc, Click Here

Cronos Group Inc. (CRON) announced towards the end of last week that meeting materials for a special meeting of shareholders of the Company to be held on February 21, 2019, including information related to the company’s planned $2.4 billion equity investment deal with Altria Group, Inc have been mailed out to all necessary parties, as well as filed with the relevant Canadian securities regulators.

For More Information On CV Sciences Inc., Click Here

What Is Stock Price (

Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for. was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.

At Stock Price (, you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

JSG Communications, LLC, which owns , may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns , may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.

Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of JSG COMMUNICATIONS LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 (CASH) for & were paid ”500,000” shares of restricted common shares (as of 1/23/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the ”500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information Please click here for full disclaimer .


SOURCE: Stock Price